IL6 and cancer: In prostate cancer, TLR2 is expressed on cancer cells and mediates the pro-tumorigenic effects induced by some pathogens such as Trichomonas vaginalis and Mycoplasma through the induction of IL-6 and IL-8 production and consequent stimulation of EMT [60,61].